Skip to content
2000
Volume 16, Issue 26
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Benzimidazole is a heterocyclic aromatic organic compound which has been an important pharmacophore and privileged structure in medicinal chemistry. Substituted benzimidazoles have considerable interest as compounds with a wide spectrum of biological activity and low toxicity. Benzimidazole derivatives are structurally related to purine nucleoside bases, which allow them to interact easily with the biopolymers of the living systems. Different substituted benzimidazoles have an extensive range of biological activities including: antiviral, antifungal, antimicrobial, antiprotozoal, antiinflammatory, anticancer, antioxidant, anticoagulant, antidiabetic and antihypertensive activities. Infectious diseases are those whose incidence in humans has increased during the past few decades. They cause suffering and death and an enormous financial burden. Antimicrobial drugs have saved the lives of millions of people. However, the dramatic increase in drug-resistant microbes is threatening to reverse medical progress of the past 50 years. Benzimidazoles are very effective compounds with respect to their bacteria inhibitory activity. Biochemical and pharmacological studies have showed that these molecules are effective against various strains of microorganisms. Some benzimidazole compounds inhibit the biosynthesis of ergosterol, required in the cell membrane of fungi and protozoa and a useful target for antifungal drugs. The result of many efforts to develop new molecules for effective antimicrobials reveals that the benzimidazoles are still one of the most versatile class of compounds against microbes.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026616666160506130226
2016-10-01
2024-11-16
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026616666160506130226
Loading

  • Article Type:
    Research Article
Keyword(s): Antibacterial; Antimicrobial; Benzimidazole; Drug discovery; Heterocyclic compounds; MRSA
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test